MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system (Q33753435)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system
scientific article

    Statements

    MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit